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1. Introduction 
In [I], we have reported the construction and 
characterization of two hybrid ColEl plasmids, 
pTUB1 and pTUB2, in which the 8.9 kilobases (kb) 
(18.6% h-unit) EcoRI fragment derived from trans- 
ducing phage XrifdlS was inserted in two different 
orientations into a ColEl derivative plasmid 
RSF2124. The 8.9 kb fragment contained a part of 
rrnB, genes for 4 tRNAs (glyT, tyrU, thrT, and thrum), 
tujB, a gene for an unidentified protein ‘U’, and a 
part of rplK [2] (fig.1). 
In a cell-free transcription-translation system, 
both pTUB1 and pTUB2 DNA could direct the syn- 
thesis of tufB mRNA and EF-Tu(B) (product of &@) 
[l]. Furthermore, the analysis of the transcripts syn- 
thesized in the presence of purified RNA polymerase 
holoenzyme has revealed that the transcription was 
initiated at a point -300 nucleotides upstream of the 
structural gene for tujB (Shibuya, A. M., Y. K., in 
preparation) and was specifically inhibited by low 
concentrations of ppGpp (A. M., Shibuya, Y. K., in 
preparation). These results suggests that the promotor 
gene for tuj73 which is under the stringent control 
may be located in close proximity to its structural 
gene. 
Here, we have studied the expression of the cloned 
tujB gene within cells of the kirromycin-resistant 
mutant LBE2012 [3,4]. The antibiotic kirromycin 
inhibits protein synthesis by preventing the release of 
EF-Tu from ribosomes [S--7]. The mutant LBE2012 
was originally thought to have the tufA mutant allele 
coding for a functional kirromycin-resistant EF-Tu(A) 
and the mutant tujB gene that produces a non-func- 
tional EF-Tu(B) [3,4]. However, the tufB product of 
LBE2012 is functional in the absence of kirromycin, 
but is inactivated in the presence of kirromycin (L. 
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Fig.1. Physical and functional map of pTUB1. The black and 
white regions in the outside circle represent he vector and 
host genoms, respectively. Locations of EcoRI and SmaI 
restriction endonuclease cleavage sites and lengths of the 
restriction fragments (in kilobases) are shown. The major 
transcription units and their directions are indicated by the 
arcs with arrows inside the map of pTUB1. The gene imm 
(closed arc) codes for the ColEl immunity. The ColEl gene 
(dotted arc) is cleaved by EcoRI near the end, and the rest of 
the gene is fused to the portion of rrnB gene at one end of the 
8.9 kb (18.6% X-unit) EcoRI fragment. The size of the EcoRI 
fragment was calculated assuming 1% h-unit as 480 basepairs 
[25]. The sum of the lengths of 4 restriction fragments in the 
EcoRI fragment determined by gel electrophoresis is 9.1 kb. 
The bacterial genes (open arcs) contain the part of rrnB, the 
genes for 4 tRNAs, tufi, the ‘U’ gene, and the part of rplK. 
The distance between the 4 tRNA genes and m$!? are from 
J. D. Friesen (personal communication). It is not clear 
whether the tRNA genes (thrU-tyrU, andglyT-thrr) and 
tufB are transcribed as a single or multiple transcription unit. 
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Bosch, personal commu~cation). Since kirromycin- 
sensitivity is dominant over kirromycin-resistance 
[3,4], the introduction of plasmids bearing the wild- 
type allele of tujB into LBE2012 would yield kirro- 
my&-sensitive transformants if the cloned &.@3 gene 
is expressed in viva. These results indicate that &&I 
in both pTUB1 and pTUB2 is indeed expressed in
transformed cells. Although the copy number of 
pTUB1 was -2Oti the transformants, the rate of the 
synthesis of EF-Tu did not increase appreciably, This 
indicates the presence of an additional regulatory 
mech~~sm that m~nt~ns the normal cellular level of 
EF-Tu . 
2. Materials and methods 
2 .‘I . Chemicals 
i3H]Leucine, f3H] serine and ~3H]~~i~e were 
obtained from the Radiochemical Centre, Amersharn. 
Kiriomycin was a kind gift from Professor H. Wolf, 
Tiibingen University. In some experiments it was 
replaced by Aurodox (X5108) [8] kindly supplied by 
Roche. 
2.2. Bacterial strains and plasmids 
The kirromycin-resistant mutant LBE2012 (tu$4 , 
tuf73, xyl) as well as its parental strain LBElOOl 
(F-, su-) [3,4] were kindly donated by Dr L. Bosch, 
Leiden University. The ColEl-derivative plasmids 
RSF2 124 (ampic~~-resistant) [9] and pCRl (kana- 
mycin-resistant) [IO] were obtained from Dr K. 
Sakaguchi, Mitsubishi Kasei Life Science Institute 
and Dr M. Yoshikawa of our institute, respectively. 
The isolation of plasmid pTUB 1 was as in [ 11. 
2.3. ~ansf~r~ti5n of E. coli c&s 
Transformation experiments done as in [ 1 I]. 
When pTUB1 or RSF2124 DNA was used for trans- 
formation, ampicillin-resistant transformants were 
selected on the L-broth plates containing 25 1.18 
~pi~~n~~. For curing of the cells harboring 
pTUBl with pCR1 DNA, the selection was carried out 
on L-broth plates containing 25 pg kanamycinlml. 
Kanamycin-resistant colonies were isolated and puri- 
fied by two successive transfers on kanamycin- 
containing plates. After the second transfer, most of 
the transfo~~ts with pCR1 (k~amyc~-resistant) 
had lost ampicillin resistance, indicating that plasmid 
pTUB1 which is incompatible with pCR1 [12,13] 
had been eliminated. 
216 
2.4. measurements of k~r~my~in-resistance 
The kirromycin-resistance of the transformant 
cells was assayed essentially as in [3]. The cells were 
grown at 37’C in an M9 medium supplemented with 
0.4% glucose. At the mid-log phase, the culture was 
divided, into 0.1 ml aliquots to which 2 mM EDTA 
and varying amounts of kirromycin (O-200 pgjml) 
were added. After incubation for 5 min at 37”C, 
5 nmol 13H]leucine (50 Ci/mol) were added to each 
tube and the mixtures were incubated further for 
20 min at 37°C. The radioactivity incorporated into 
the hot 4% perchloric and-insoluble fraction was 
determined. 
2.5. Differential rate ofEF-Tu synthesis 
Escherichia coli cells were grown in 2 ml 0.4% 
glucose-M9 medium at 37OC. When As60 reached 
0.1, the culture was supplemented with 5 PCi 
[3H] serine (20 Ci/mmol) and incubated for 2 min 
at 37°C. The [3H]serine was then chased with an 
excess of unlabeled serine (1 mM) for 3 min at 37°C. 
The synthesis of total cellular protein was determined 
by incorporation of the radioactivity into the hot 
perchloric acid-~solubie fraction, and that of EF-Tu 
by immunoprecipitation-ebctrophoresis a  in [ 141. 
The differential rate of the synthesis of EF-Tu was 
calculated as: 
Rate of the synthesis of EF-Tu 
Rate of the synthesis of total cellular pro&& 
x 100 
3. Results 
The ~rromyc~-sensitive or -resistant phenotype 
of LBElOOl, and LBE2012 and its transformants 
with pTUB 1 or RSF2 124 were assessed by their abil- 
ity to incorporate labeled leucine into protein in the 
presence of various concentrations of kirromycin. As 
shown in fig.2, incorporation of the labeled amino acid 
was not inhibited by kirromycin in the kirromycin- 
resistant mutant LBE2012 or in its transformant with 
the vector plasmid RSF2124. On the other hand, the 
transformant of LBE2012 with pTUB1, LBE2012 
(pTUB1) was as sensitive as the kirromycin-sensitive 
parental strain LBElOOl . These results indicate that 
the kirromycin-resistant phenotype of LBE2012 was 
altered to give the kirromycin-sensitive phenotype 
upon introduction of the plasmid pTUB1, and suggest 
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Fig.2. Suppression of kirromychr-resistance in LBE2012 by 
transformation with pTUB1. The activity to incorporate 
[3H]leucMe into protein of LBElOOl (e), LBE2012 (A), 
LBE2012 (RSF2124) (o) and LBE2012 (pTUB1) (A) cells 
was plotted as a function of kirromycin concentrations. 
Assay conditions were as in section 2. 
that the cloned wild-type tz@ is expressed in the 
transformant cells. 
To exclude an alternate possibility that the above 
observation is due to the recombination of tu_fB in 
plasmid DNA with chromosomal genes for tufA or 
@fB, the following experiments were done. Since two 
different ColEl plasmids are mutually incompatible 
in the same host [12,13], the introduction of the 
kanamycin-resistant ColEl plasmid pCR1 into 
LBEZO 12 (pTUB1) and selection for kanamycin- 
resistance would result in the elimination of pTUB1. 
The results in fig.3 indicate that the kirromycin- 
resistant phenotype was completely restored on dis- 
placement of pTUB1 by pCRl , thus proving unequi- 
vocally that the kirromycin-sensitivity in LBE2012 
(pTUB1) is due to the direct expression of tuj2l in 
the cloned plasmid. 
Since the replication of ColEl plasmids is under 
‘relaxed’ control [ 151, the copy number of pTUB1 
in the transformant cells is increased. As shown in 
table 1, there are -20 copies of plasmids in LBE20 12 
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Fig.3. Displacement of pTUB1 in LBE2012 cells by pCR1. 
Incorporation of [ 3H Jleucine into protein at various concen- 
trations of khromycih was measured with LBE2012 (pTUB1) 
(0) and LBE2012-(pCR1) (0) cells. The Latter strain was con- 
structed by transformation of the former with pCR1 fol- 
lowed by selection with kanamycin. For details, see the text. 
cells infected with either pTUB1 or its vector 
RSF2124. We then measured the rate of synthesis 
of EF-Tu in cells transformed with pTUB1 or 
RSF2 124, to see whether there is any overproduction 
of EF-Tu due to the increase in the number of the 
functional tu_fB gene within the cells. As shown in 
Table 1 
Lack of gene dosage effect on the synthesis of EF-TU 
Strain Copy number 
of plasmidsa 
Differential rate of 
EF-Tu synthesisb (%) 
LBE2012 
(RSF2124) 23,14,18 4.9 
LBE2012 
@TUBI) 24,17 5.1 
a Plasmid copy numbers in LBE2012 were determined by 
CsCl-ethidium bromide centrifugation of the [3H]thymi- 
dine-labeled cells lysates according to [ 16 1. The radioactiv- 
ity found at the position of the covalently closed circular 
plasmid DNA was used to calculate the plasmid copy num- 
ber. The values are expressed as plasmid copies per chromo- 
some equivalent and were calculated assuming IQ 2.5 X lo9 
for the E. co/i chromosome, 7.4 X lo6 for RSF2124, and 
1.3 X 10’ for pTUB 1. The individual vahres were obtained 
from separate xperiments 
b Determined as in section 2 
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table 1, there was practically no increase in the dif- 
ferential rate of the synthesis of EF-Tu in LBE20 12 
cells containing multicopies of tr.@. 
4. Discussion 
These experiments prove that tujB gene cloned 
on a ColEl plasmid pTUB1 [l] is expressed in the 
kirromycin-resistant mutant LBE2012. With the 
results of the cell-free system [l] and those to be 
reported elsewhere (see section l), it appears that 
tujB possesses a promotor adjacent to its structural 
gene. The plasmid pTUB2 which contains the inserted 
8.9 kb EcoRI fragment in an opposite orientation 
pas expressed equally well in the cell-free system [l] 
but somewhat weakly in LBE2012 (not shown). This 
might be due to the presence of a small deletion in 
pTUB2 upstream of its coding region (A. M., Y. 
Takebe, unpublished). Another plasmid pTUA1 which 
contains a 4 kb (8 ~5% X-unit) EcoRI fragment derived 
from phage xfus3 was only weakly expressed in the 
cell-free system due to the lack of the natural promoter 
in the cloned fragment [ 171. The expression of 
pTUA1 in whole cells of LBE2012 assessed as in the 
present experiment was also weak (A. M., unpub- 
lished). 
The synthesis of EF-Tu was not appreciably 
increased in the transformant LBE2012 (pTUB1) 
cells, in spite of the presence of -20 copies of the 
plasmid. It is of interest to note that the lack of gene 
dosage effect has been reported for the synthesis of 
ribosomal proteins [ 18-241 and of the /3 and 0’ sub- 
units of RNA polymerase [ 171. In some cases [20,21, 
231, it has been shown that the rate of transcription of 
mRNA increases as the number of the corresponding 
gene copies increases, yet no dosage effect was 
observed in the synthesis of the respective proteins. 
This suggests that expression of these genes may be 
regulated by post-transcriptional control, including 
the inactivation or degradation of mRNA. This regu- 
lation was interpreted by a model in which free ribo- 
somal proteins, when overproduced, selectively inac- 
tivate their own mRNA by a feedback mechanism 
[ 19,20,24]. It remains to be seen whether the similar 
regulatory mechanism may be present in the case of 
EF-Tu biosynthesis. 
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